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Hyperosmolar diabetic non-ketotic coma, hyperkalaemia and
an unusual near death experience
J.Y.S. TING
Department of Emergency Medicine, Princess Alexandra Hospital, Woolloongabba 4102 Brisbane, Queensland, Australia
Generally, cardiac arrest due to pulseless electrical activity has a poor outcome, except when
reversible factors such as acute hyperkalaemia are identified and managed early. Hyperos-
molar diabetic non-ketotic coma may lead to acute hyperkalaemia. Hyperosmolar diabetic
non-ketotic coma is a metabolic emergency usually seen in elderly non-insulin dependent
diabetics, characterized by severe hyperglycaemia, volume depletion, altered consciousness,
confusion and less frequently neurological deficit. Cerebrovascular accident or transient is-
chaemic attack may be mistakenly diagnosed, particularly if the patient has no history of
diabetes mellitus. Delays in diagnosis and management of glycaemic emergencies presenting
as a constellation of neurological abnormalities can be avoided by routine early measurement
of blood glucose. Hyperosmolar diabetic non-ketotic coma should be considered in any patient
with altered consciousness or neurologic deficit in conjunction with hyperglycaemia. As
hyperosmolar diabetic non-ketotic coma results in severe fluid depletion, electrolyte distur-
bance, profound hyperglycaemia and an altered mental state, the guiding principles of therapy
include aggressive rehydration, insulin therapy, correction of electrolyte abnormalities and
treatment of any underlying illnesses. Treatment of acute hyperkalaemia includes calcium ions,
insulin with dextrose, salbutamol and haemodialysis.
 2001 Lippincott Williams & Wilkins.
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INTRODUCTION
This case reports a diagnostically complex conjunc-
tion of acute hyperkalaemia due to hyperosmolar
diabetic non-ketotic coma leading to a pulseless elec-
Ž .trical activity PEA cardiac arrest. Rapid recognition
and treatment of these life-threatening disease
processes resulted in the patient’s full recovery. This
is in contrast to the poor outcome for PEA in general.1
A review of the management of acute hyperkalaemia
and hyperosmolar diabetic non-ketotic coma is pre-
sented.
CLINICAL RECORD: AN UNUSUAL NEAR
DEATH EXPERIENCE
A 54-year-old woman suffered an unwitnessed PEA
cardiac arrest at home. Field paramedics adminis-
Ž . Žtered intravenous adrenaline 1 mg and atropine 3
.mg to treat a wide complex bradyarrhythmia with
Ž .no cardiac output Fig. 1 . This resulted in return of a
circulation.
On arrival at the emergency department, her temper-
ature was 36.4oC, respiratory rate 18 breathsminute
and oxygen saturation 97% on 6 lmin of oxygen.
She had a wide complex regular tachyarrhythmia of
120 beatsminute with a blood pressure of 10060
Ž .mmHg Fig. 2 .
ŽThe patient had a Glasgow Coma Score of 13 E4 V4
.M5 and mid-size equally reactive pupils. She local-
ized to noxious stimuli, but had no movement on her
left side. Brisk symmetrical lower limb reflexes and
bilateral down going plantar responses were elicited.
No neck stiffness, facial weakness, external signs of a
head injury or rash was present.
Ž .Her blood sugar level BSL registered ‘high’ on the
glucometer. Results of arterial blood gases on 40%
inspired oxygen include pH 7.27, pCO 35 mmHg,2
 pO 233 mm, bicarbonate 15 mmoll, base deficit2
 10.7 mmoll and K 6.8 mmoll.
Intravenous administration of 10 ml 10% calcium
chloride resulted in normalization of the QRS dura-
tion. No acute ischaemic change was present on her
Ž .12 lead ECG Fig. 3 . Treatment with an intravenous
insulin infusion and normal saline rehydration led to
resolution of her confusional state, hemiplegia and
metabolic derangements over 48 hours.
 2001 Lippincott Williams & Wilkins.
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Fig. 1. Paramedic ECG strip showing a wide complex bradyarrhythmia without cardiac output.
A history of poorly controlled non-insulin dependent
Ž .diabetes mellitus NIDDM , chronic obstructive pul-
monary disease, depression and heavy alcohol intake
became available at this stage.
 Serum biochemistry at admission revealed Na 111
Ž .   Ž .   135145 mmoll , K 6.8 3.24.5 mmoll , Cl
Ž .   Ž72 100110 mmoll , bicarbonate 12 2233
. Ž .mmoll , creatinine 0.16 0.050.10 mmoll , urea
Ž .   Ž .17.1 3.08.0 mmoll , glucose 80 3.07.8 mmoll ,
Ž .calculated osmolality 312 270290 mmolkg and
Ž .measured osmolality 331 275295 mmolkg . The
Žanion gap of 27 was raised for her age predicted 17
.mmoll . Urinalysis showed 1 ketones, 2 glu-
cose and 1 protein. Her haemoglobin was 118
Ž . Ž 9 .115160 gl , white cell count 10.2 4.011.010 l
Ž 9 .and platelets 196 14040010 l . A clean catch
catheter urine specimen grew Escherichia coli.
There was no history of an ingestion of calcium
Fig. 2. First ECG in the emergency department demonstrating wide complex tachyarrhythmia.
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Fig. 3. Normalization of ECG after calcium chloride administration.
channel or beta-blockers, tricyclic antidepressants and
digoxin. Screening for paracetamol, salicylate and
ethanol was negative. A diagnosis of PEA cardiac
arrest from acute hyperkalaemia due to hyperos-
molar diabetic non-ketotic coma was made.
DISCUSSION
Pulseless electrical activity
PEA occurs when there is no detectable pulse in the
presence of organized electrocardiographic activity.
Well-known causes of PEA include myocardial is-
chaemia, pericardial tamponade, hypovolaemia, pul-
monary thromboembolism and tension pneumo-
thorax.2 PEA is the initial rhythm in 17% of out-of-
hospital cardiac arrests and has a poor outcome with
only 4.4% of victims surviving to discharge from
hospital.1 Acute hyperkalaemia is a rare precipitant of
PEA3,4 with diabetes mellitus being a comorbid con-
dition in 15% of cases.5
Hyperkalaemia
Despite a total body deficit of potassium in hyperos-
molar diabetic non-ketotic coma and diabetic
Ž .ketoacidosis DKA , hyperkalaemia can be present
initially.6,7 Hyperosmolality due to hyperglycaemia
causes osmotic shift of intracellular fluid into the
extracellular compartment accompanied by passive
potassium efflux out of cells.4 Insulin deficiency, de-
hydration with impaired renal perfusion and acidosis
also contribute to the development of hyper-
kalaemia.4,8
Hyperkalaemia causes cardiac rhythm disturbances
by altering cell membrane resting and threshold po-
tentials. A biphasic response to hyperkalaemia is seen.
Initially the resting potential is brought closer to
threshold and depolarization is facilitated with an
increase in membrane excitability. Worsening hyper-
kalaemia reduces membrane sodium permeability
thereby retarding sodium influx and cell excitability.
Typical ECG manifestations of hyperkalaemia in-
clude peaked T waves, loss of P waves, prolonged PR
interval, intraventricular conduction defect and sec-
ond-degree atrioventricular block. This may progress
to widened QRS complexes and a sine wave pattern
that precedes asystole. Ventricular tachyarrhythmias
and asystole can occur at any level of hyperkalaemia.
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The evolution of these rhythm disturbances is unpre-
dictable and there is no correlation between severity
 of hyperkalaemia and ECG changes. Acute K
greater than 6 mmoll requires urgent treatment.8
Immediate treatment aims to ameliorate the
destabilizing cardiac membrane effects of hyper-
kalaemia, shift extracellular potassium into cells and
bind to potassium within the gastrointestinal tract.
Although calcium chloride or gluconate can reverse
hyperkalaemia-induced cardiac arrhythmia within
minutes, they do not lower potassium levels and are
therefore only of temporary benefit.8 The patient had
a hyperkalaemia-induced wide-complex tachy-
arrhythmia which responded well to calcium chlor-
ide.
Measures to lower potassium levels8 need to be insti-
tuted after initial myocardial stabilization with cal-
cium. Insulin reliably shifts potassium into cells
within 20 minutes. Both an intravenous bolus of 10
units of soluble insulin with 50 ml 50% dextrose or an
insulin infusion at 510 units per hour are effective.
An infusion is preferred if control of hyperglycaemia
is also needed.
Intravenous salbutamol can immediately lower
potassium levels and a nadir is seen at 90120 min-
utes, whereas the effects of nebulized salbutamol has
a delayed onset and peak. However, a third of
patients with hyperkalaemia fail to respond with this
therapy. As there is mounting evidence that bicarbo-
nate is unreliable therapy for hyperkalaemia, it should
only be administered to treat a coexistent profound
acidosis.8
Even though haemodialysis is the most rapid and
effective way to lower serum potassium, it is re-
served for patients who fail to respond to pharmaco-
logic therapy or require dialysis for another indica-
tion such as uraemia, acidosis and fluid overload due
to renal failure. Access to the central circulation is
required and it takes time and expertise to set up and
run. There is a risk of rebound hyperkalaemia after
dialysis is completed. Orally or rectally administered
exchange resins which bind to enteric potassium are
effective in reducing gastrointestinal absorption but
are delayed in onset.8
Hyperosmolar diabetic non-ketotic coma
In 1886, Dreschfeld9 described a metabolic disorder
characterized by ‘drowsiness, soon passing into coma
. . . confined to older diabetics who are still stout and
well nourished at the time of the attack’. Hyperos-
molar diabetic non-ketotic coma was first described
as a clinical entity by Schwartz in 1957.10 It is a
life-threatening endocrine emergency, comprising
1020% of diabetic comas, with other forms being
DKA and hypoglycaemic coma.11,12
Diagnostic criteria include extreme hyperglycaemia
 with serum glucose  33 mmoll, increased serum
osmolality 320 mmolkg, mild ketoacidosis with
  3  urinary ketones and serum ketone  5
 mmoll. The arterial pH is  7.2 and bicarbonate
remains 15 mmoll, unlike in DKA where signifi-
cant metabolic acidosis is a prominent feature.10,13 15
Typically hyperosmolar diabetic non-ketotic coma oc-
Ž .curs in an elderly mean age 5575 years dehydrated
patient presenting with confusion and reduced con-
sciousness level. Even though it is most commonly
associated with known NIDDM, a third of cases
occur in newly diagnosed diabetics.11,13,16 To compli-
cate matters further, hyperosmolar diabetic non-keto-
tic coma can occur in younger insulin-dependent
diabetics with previous episodes of DKA. Progressive
hyperglycaemia with polyuria occurs with poor oral
fluid intake, leading to severe dehydration.11,15
Hyperosmolar diabetic non-ketotic coma constitutes
part of a spectrum of severe metabolic disturbance in
diabetes mellitus ranging from pure hyperglycaemic
hyperosmolarity with non-significant ketoacidosis to
DKA, with overlapping features in a third of
patients.12,15 A relative deficiency of insulin leads to
hyperglycaemia. Unlike in DKA, there is no signifi-
cant ketogenesis due to the presence of low levels of
endogenous insulin sufficient to inhibit lipolysis but
not gluconeogenesis. Lesser amounts of free fatty
acid is diverted into ketogenic pathways.6,11,12,15 Pre-
cipitants are varied and include cerebrovascular acci-
Ž . Ždents CVA , infection most common precipitant,
.seen in 60% of cases , intercurrent illness, non-com-
pliance with diabetic treatment, alcohol abuse, myo-
cardial ischaemia, acute gastrointestinal illness and
surgically induced stress.7,15 A symptomatic E. coli
urinary tract infection precipitating glycaemic de-
compensation may have contributed to our subject’s
acute presentation.
Hyperosmolar diabetic non-ketotic coma results in
severe fluid depletion, electrolyte disturbance, pro-
found hyperglycaemia and an altered mental state.6,7
The guiding principles of therapy include aggressive
rehydration, correction of electrolyte abnormalities,
insulin therapy and treatment of any underlying ill-
nesses.17
Hypoperfusion and hypotension requires aggressive
fluid resuscitation until haemodynamic stability is
achieved. Colloids and vasopressors are required if
there is an inadequate response to fluid therapy.12
Low cardiac output states due to myocardial dys-
function and arrhythmias require early identification
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and treatment. Even if there is no haemodynamic
disturbance, fluid depletion is severe. Deficits in the
Ž .order of 100200 mlkg mean 912 litres result
from the insidious evolution of hyperglycaemic de-
compensation over days to weeks10,12,14,18 with failure
to respond to thirst due to altered conscious state12
and compromised access to fluids.15
The majority of authors6,10,12,15,19 advocate initial ex-
Ž .pansion of circulating volume with normal 0.9%
saline in most cases of hyperosmolar diabetic non-ke-
totic coma as marked total body sodium deficit exists
 despite high or normal serum Na and it is main-
tained within the intravascular space for a longer
period than hypotonic fluids.6,7,12 In addition to re-
placement of sodium deficit, a more gradual lower-
ing of serum tonicity is possible compared with dex-
trose-only solutions, reducing the risk of cerebral
oedema especially in children aged less than 5 years
who are more prone to this complication.12,17 How-
ever, use of normal saline can lead to hypernatraemic
hyperchloraemic acidosis.12,19
Vigilant assessment of haemodynamic and metabolic
response to resuscitation remains the keystone in
fluid therapy.6 5001000 mlh of normal saline will
be required until haemodynamic stability is attained
Ž .usually achieved in the first 2 hours . Thereafter
Ž .250750 mlh of half 0.45% normal saline is admin-
istered in the next 4 hours according to acuity and
severity of fluid deficit.6,12,15,20 5% dextrose is added
 to the fluid regimen when serum glucose declines to
15 mmoll to prevent hypoglycaemia.6,7,15 Half the
fluid and electrolyte deficit is replaced in the first 12
24 hours,7,10 aiming for a serum osmolarity of 320
  12mOsmkg and serum glucose of 15 mmoll, with
a slower rate of correction taking place over the next
48 hours.15,17 Cautious volume replacement with cen-
tral venous pressure monitoring is warranted if there
is limited cardiorespiratory reserve or renal impair-
ment, with strict attention to fluid balance and close
monitoring of urine output.6,7
Berger7 and Small11 advocate specific fluid regimens
that are appropriate to the level of hypernatraemia.
 Normal saline is used if serum Na is less than 145
mmoll. More severe hypernatraemia requires rela-
tively more rapid reduction of hyperosmolarity with
lesser concentrations of sodium chloride containing
intravenous fluids. For instance, half normal saline is
 used when serum Na is 145165 mmoll, with
 2.5% glucose proposed if serum Na is greater than
165 mmoll. Matz12 recommends hypotonic fluids if
serum osmolarity is greater than 320 mOsml and
isotonic fluids if serum osmolarity is less than 320
mOsml. However, serum osmolarity will not be
immediately available to determine the type of fluid
best suited to the patient.
 In this patient, serum Na has been artefactually
lowered to 111 mmoll by severe elevation in serum
 glucose , which causes free fluid to shift from the
intracellular to extracellular compartment, therefore
 diluting serum Na . Every 3.47 mmoll of serum
   glucose will lower serum Na by 1 mmoll when
severe hyperglycaemia is present, reflecting pseudo-
21  hyponatraemia. The corrected serum Na in this
patient would have been approximately 134 mmoll
Ž .normal 140 mmoll , with the remaining 6 mmoll
of dilution being attributable to increased water re-
tention due to inappropriately excessive anti-diuretic
hormone secretion in an attempt to preserve extracel-
lular volume18,22 and insulin’s antinatriuretic effect
on the kidney.12
After a intravenous loading dose of 0.1 ukg of
soluble insulin, a low dose infusion of 0.1 ukgh
Ž .510 uh is employed to gradually lower serum
  6,14,15,19  glucose . The aim is to reduce serum glucose
by 5 mmoll every hour. More rapid attempts to
achieve euglycaemia using higher doses of insulin
Ž 18 .50100 u every hour intra-muscularly is associ-
ated with a 25% risk of acute hypokalaemia and
hypoglycaemia and are no longer used.15 Further-
more, there is no evidence that high dose insulin
interrupts ketogenesis and corrects metabolic de-
rangements more effectively than a low dose infu-
sion.6,15,19 Aggressive correction of hyperglycaemia
without repletion of fluid deficit may lead to vascular
 collapse from rapid reduction in serum glucose and
acute shift of free water from the intravascular to
intracellular space.12,15 In the severely dehydrated
state, hyperosmolar plasma helps to preserve circu-
lating volume.14 High-dose insulin causes relative
serum hypotonicity with free fluid shifting into neu-
rons rapidly leading to cerebral oedema in children.17
This rarely occurs in adults.6 As such, insulin infu-
sion rate should be slowed down to 0.05 ukgh or 2
uh once BSL reaches 15 mmoll12 and titrated ac-
  6,15cording to hourly serum glucose measurements.
17  Ellis recommends maintaining serum glucose at
1015 mmoll for the first 24 hours prior to further
reduction to reduce risks of cerebral oedema. On the
other hand, hyperglycaemia that is resistant to low
dose insulin despite volume correction requires in-
creased insulin infusion.15
Substantial total body potassium depletion occurring
in hyperosmolar diabetic non-ketotic coma is the con-
sequence of brisk osmotic kaliuresis. The degree of
total body potassium depletion is often underesti-
  12mated because of initially elevated or normal K ,
which masks total body K deficit. This is main-
tained by intravascular volume contraction in excess
of K losses, insulin deficiency and acidosis-induced
transcellular shift of K from the intracellular into
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6,7,15  extracellular compartment. A low serum K
therefore suggests severe potassium depletion15 and
therefore requires aggressive K replacement at 40
mmolh.6,7 If initial hyperkalaemia is present, K
replacement can be safely administered once serum
 K falls below 5.5 mmoll, at a rate of 20
mmolh.6,7,12,14 Replenishment is started provided
there is an adequate urine output, with 70% of K
administered being lost in the urine in the first 24
6,7  hours. Complex shifts in serum K during the
acute phase of treatment mandates close hourly mea-
  12surement of serum K . If there is concurrent hy-
pophosphataemia, potassium phosphate is preferred
over potassium chloride, with the latter exacerbating
hyperchloraemia.12
Although phosphate replacement makes physiologic
sense, there is no controlled data to show that it alters
 outcome in uncontrolled diabetes unless phosphate
is less than 0.5 mmoll or the patient is
symptomatic.7,15 Routine phosphate replacement is
therefore not indicated14,15 because levels return to
normal with rehydration and insulin therapy.14 Phos-
phate ions can be administered at 1015 mmolh.6
Routine administration of magnesium in hyperos-
molar diabetic non-ketotic coma is safe and physio-
logically appropriate if levels fall below 0.6 mmoll.7
There is no evidence to support the use of bicarbo-
nate in hyperosmolar diabetic non-ketotic coma when
arterial pH is greater than 7.1. Adverse effects of
bicarbonate adminstration include hyperosmolar load
and paradoxical intracellular acidosis within the cen-
tral nervous system.7,15,18 It is recommended that 44
mmol of bicarbonate and 15 mmol of K be given
every 2 hours until pH is greater than 7.15 Empiric
Žbroad-spectrum antibiotics covering Gram negative
.organisms pending culture results may be beneficial
if the patient is febrile or critically ill.6 The risk of
thromboembolic events due to hyperviscosity in hy-
perosmolar diabetic non-ketotic coma is reduced with
prophylactic doses of subcutaneous heparin. Full an-
ticoagulation carries a high risk of gastrointestinal
bleeding.6,7 Most patients need to be managed in an
intensive care unit.10,20
Early detection and treatment of underlying precipi-
Ž .tants present in 50% of hyperosmolar diabetic non-
ketotic coma such as acute myocardial infarction,
CVA and sepsis is crucial if the patient is to have an
improved outcome. Addressing patient non-compli-
ance with diabetic therapy is important in preventing
further episodes of glycaemic decompensation.6,7
The main causes of death are sepsis, metabolic and
cardiovascular decompensation,6 thromboembolic
complications and renal failure.11,13 Mortality rates
for hyperosmolar diabetic non-ketotic coma is three-
fold higher than for DKA, ranging from 10% to
70%,10,12,16 reflecting severe metabolic disturbances in
elderly patients with prior comorbidities.10 Delayed
diagnosis is contributory and as a third of patients
have no history of diabetes mellitus, a high index of
suspicion needs to be maintained.12,13,15,16 Inadequate
treatment and specifically under-resuscitation19 also
plays a part in high mortality rates that have not
changed despite advances in diabetic care.17
CVA can precipitate or become a complication of
hyperosmolar diabetic non-ketotic coma, with dia-
betes mellitus being a well-recognized risk factor for
thrombotic CVA.23 Thirty per cent of patients with
hyperosmolar diabetic non-ketotic coma have re-
versible neurological deficits that may mimic
CVA.12,20 A quarter of patients are unconscious on
presentation.12,15 On the other hand, prolonged hy-
poglycaemia will result in neurological damage.
Therefore all patients presenting with neurological
deficit, altered consciousness or confusion should
have an early BSL measurement to detect and treat
any glucose abnormality. Hyperosmolar diabetic
non-ketotic coma needs to be considered when hy-
perglycaemia occurs in this situation.
This case illustrates an unusual complication of hy-
perosmolar diabetic non-ketotic coma, that of pulse-
less electrical activity cardiac arrest due to hyper-
kalaemia-related arrhythmia. Haemodynamic,
metabolic and neurological recovery was achieved by
early recognition and treatment of these life-threaten-
ing processes.
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